{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:10:04Z","timestamp":1793293804225,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020916","name":"HUN-REN Hungarian Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020916","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.isci.2024.109284","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T02:53:47Z","timestamp":1708397627000},"page":"109284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["P2X7 receptor inhibition alleviates mania-like behavior independently of interleukin-1\u03b2"],"prefix":"10.1016","volume":"27","author":[{"given":"Fl\u00f3ra","family":"G\u00f6l\u00f6ncs\u00e9r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Baranyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Tod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fruzsina","family":"Ma\u00e1cz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"Sperl\u00e1gh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.109284_bib1","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.isci.2024.109284_bib2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.biopsych.2021.09.008","article-title":"Longitudinal Structural Brain Changes in Bipolar Disorder: A Multicenter Neuroimaging Study of 1232 Individuals by the ENIGMA Bipolar Disorder Working Group","volume":"91","author":"Ab\u00e9","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.isci.2024.109284_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.mp.4001585","article-title":"The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings","volume":"10","author":"Strakowski","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.isci.2024.109284_bib4","article-title":"Overlapping evidence of innate immune dysfunction in psychotic and affective disorders","volume":"2","author":"Hughes","year":"2020","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.isci.2024.109284_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12929-021-00742-6","article-title":"Inflammatory signaling mechanisms in bipolar disorder","volume":"28","author":"Jones","year":"2021","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.isci.2024.109284_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105325","article-title":"Inflammation in Bipolar Disorder (BD):\u00a0Identification of new therapeutic targets","volume":"163","author":"Pereira","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2024.109284_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11920-014-0541-1","article-title":"Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites","volume":"17","author":"Anderson","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.isci.2024.109284_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.psc.2015.09.006","article-title":"Bipolar Disorder and Inflammation","volume":"39","author":"Rosenblat","year":"2016","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.isci.2024.109284_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.isci.2024.109284_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1503\/jpn.100080","article-title":"Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder","volume":"36","author":"S\u00f6derlund","year":"2011","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.isci.2024.109284_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnana.2019.00048","article-title":"The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation","volume":"13","author":"Ferrucci","year":"2019","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.isci.2024.109284_bib12","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1476-5381.2011.01318.x","article-title":"Predictive animal models of mania: hits, misses and future directions","volume":"164","author":"Young","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.isci.2024.109284_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuroscience.2015.08.041","article-title":"Animal Models of Bipolar Mania: The Past, Present and Future","volume":"321","author":"Logan","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.isci.2024.109284_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbr.2019.01.006","article-title":"Questioning the predictive validity of the amphetamine-induced hyperactivity model for screening mood stabilizing drugs","volume":"362","author":"Lan","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.isci.2024.109284_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.12740\/PP\/97335","article-title":"Disturbances of purinergic system in affective disorders and schizophrenia","volume":"53","author":"Malewska-Kasprzak","year":"2019","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.isci.2024.109284_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pnpbp.2014.10.016","article-title":"Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics","volume":"57","author":"Ortiz","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.isci.2024.109284_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40263-022-00934-0","article-title":"The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder","volume":"36","author":"Gon\u00e7alves","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.isci.2024.109284_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 Receptor in Infection and Inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2024.109284_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12035-014-9031-z","article-title":"Role of P2X7 Receptor in an Animal Model of Mania Induced by D-Amphetamine","volume":"53","author":"Gubert","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2024.109284_bib20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bph.12314","article-title":"Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567","volume":"170","author":"Bhattacharya","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.isci.2024.109284_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S1461145711001933","article-title":"The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice","volume":"16","author":"Cs\u00f6lle","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.isci.2024.109284_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066547","article-title":"Neurochemical Changes in the Mouse Hippocampus Underlying the Antidepressant Effect of Genetic Deletion of P2X7 Receptors","volume":"8","author":"Cs\u00f6lle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.109284_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104773","article-title":"The P2X7 receptor in activated microglia promotes depression- and anxiety-like behaviors in lithium -pilocarpine induced epileptic rats","volume":"138","author":"Hong","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.isci.2024.109284_bib24","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s12035-019-01817-0","article-title":"P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study","volume":"57","author":"Gubert","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2024.109284_bib25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1177\/0269881119872173","article-title":"Antidepressant-like effect induced by P2X7 receptor blockade in FSL rats is associated with BDNF signalling activation","volume":"33","author":"Ribeiro","year":"2019","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.isci.2024.109284_bib26","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1177\/0269881120914206","article-title":"Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial","volume":"34","author":"Recourt","year":"2020","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.isci.2024.109284_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41398-023-02557-5","article-title":"Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder","volume":"13","author":"Recourt","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.isci.2024.109284_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109366","article-title":"The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside","volume":"224","author":"von M\u00fccke-Heim","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.isci.2024.109284_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.psyneuen.2018.08.015","article-title":"Emerging role of the P2X7-NLRP3-IL1beta pathway in mood disorders","volume":"98","author":"Bhattacharya","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.isci.2024.109284_bib30","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","article-title":"The P2X7 receptor: a key player in IL-1 processing and release","volume":"176","author":"Ferrari","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2024.109284_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12974-017-0865-y","article-title":"Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors","volume":"14","author":"Yue","year":"2017","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.isci.2024.109284_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174148","article-title":"Time-dependent changes in striatal monoamine levels and gene expression following single and repeated amphetamine administration in rats","volume":"904","author":"Sequeira-Cordero","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.isci.2024.109284_bib33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/jpet.104.066712","article-title":"P2X receptor activation elicits transporter-mediated noradrenaline release from rat hippocampal slices","volume":"310","author":"Papp","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.isci.2024.109284_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fnmol.2017.00325","article-title":"Regulation of Hippocampal 5-HT Release by P2X7 Receptors in Response to Optogenetic Stimulation of Median Raphe Terminals of Mice","volume":"10","author":"G\u00f6l\u00f6ncs\u00e9r","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.isci.2024.109284_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2024.109284_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","article-title":"Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise","volume":"33","author":"Felger","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.isci.2024.109284_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663102","article-title":"Immunomodulatory Effects of Dopamine in Inflammatory Diseases","volume":"12","author":"Feng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2024.109284_bib38","article-title":"Neuroinflammation and glial cell activation in mental disorders","volume":"2","author":"Almeida","year":"2020","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.isci.2024.109284_bib39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fnmol.2019.00331","article-title":"Pathological ATPergic Signaling in Major Depression and Bipolar Disorder","volume":"12","author":"Illes","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.isci.2024.109284_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-017-9593-0","article-title":"The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression","volume":"14","author":"Burnstock","year":"2018","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.isci.2024.109284_bib41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fphar.2018.00052","article-title":"The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?","volume":"9","author":"Savio","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2024.109284_bib42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/mp.2017.188","article-title":"Purinergic system in psychiatric diseases","volume":"23","author":"Cheffer","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.isci.2024.109284_bib43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10519-006-9093-4","article-title":"Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease","volume":"37","author":"Einat","year":"2007","journal-title":"Behav. Genet."},{"key":"10.1016\/j.isci.2024.109284_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2009.09.040","article-title":"Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder","volume":"207","author":"Dencker","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.isci.2024.109284_bib45","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/1440-1681.13243","article-title":"Lithium attenuates d-amphetamine-induced hyperlocomotor activity in mice via inhibition of interaction between cyclooxygenase-2 and indoleamine-2,3-dioxygenase","volume":"47","author":"Phan","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.isci.2024.109284_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000515594","article-title":"Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells","volume":"28","author":"Bauer","year":"2021","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.isci.2024.109284_bib47","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/1516-4446-2017-0001","article-title":"Effects of lithium on inflammatory and neurotrophic factors after an immune challenge in a lisdexamfetamine animal model of mania","volume":"41","author":"Bristot","year":"2019","journal-title":"Braz. J. Psychiatry."},{"key":"10.1016\/j.isci.2024.109284_bib48","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11481-018-9780-y","article-title":"Inflammasome Activation by Methamphetamine Potentiates Lipopolysaccharide Stimulation of IL-1beta Production in Microglia","volume":"13","author":"Xu","year":"2018","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.isci.2024.109284_bib49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/bdi.12299","article-title":"Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine","volume":"17","author":"Valvassori","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.isci.2024.109284_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbi.2022.09.012","article-title":"Purinergic P2X7 receptor antagonist inhibits methamphetamine-induced reward, hyperlocomotion, and cortical IL-7A levels in mice: A role for P2X7\/IL-17A crosstalk in methamphetamine behaviors?","volume":"107","author":"Potula","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.isci.2024.109284_bib51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbi.2021.07.014","article-title":"Peripheral levels of C-reactive protein, tumor necrosis factor-alpha, interleukin-6, and interleukin-1beta across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability","volume":"97","author":"Solmi","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.isci.2024.109284_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134575","article-title":"P2X(7) receptor knockout mice display less aggressive biting behaviour correlating with increased brain activation in the piriform cortex","volume":"714","author":"Smith","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.isci.2024.109284_bib53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12035-009-8053-4","article-title":"A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters","volume":"39","author":"Robertson","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2024.109284_bib54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1196\/annals.1369.064","article-title":"Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs","volume":"1074","author":"Rothman","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.isci.2024.109284_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10030160","article-title":"Purinergic Signaling and Related Biomarkers in Depression","volume":"10","author":"Bartoli","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.isci.2024.109284_bib56","doi-asserted-by":"crossref","first-page":"514","DOI":"10.30773\/pi.2016.12.31","article-title":"The Relationship between the Number of Manic Episodes and Oxidative Stress Indicators in Bipolar Disorder","volume":"15","author":"Akarsu","year":"2018","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.isci.2024.109284_bib57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/bdi.12980","article-title":"Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls","volume":"23","author":"Jim\u00e9nez-Fern\u00e1ndez","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.isci.2024.109284_bib58","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1038\/s41598-017-03813-7","article-title":"Neuronal P2X7 receptor-induced reactive oxygen species production contributes to nociceptive behavior in mice","volume":"7","author":"Munoz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.109284_bib59","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.4049\/jimmunol.1301058","article-title":"Leukotriene B4 modulates P2X7 receptor-mediated Leishmania amazonensis elimination in murine macrophages","volume":"192","author":"Chaves","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2024.109284_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007887","article-title":"Non-canonical NLRP3 inflammasome activation and IL-1beta signaling are necessary to L. amazonensis control mediated by P2X7 receptor and leukotriene B4","volume":"15","author":"Chaves","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2024.109284_bib61","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/art.33355","article-title":"NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout","volume":"64","author":"Amaral","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.isci.2024.109284_bib62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1399-5618.2006.00318.x","article-title":"Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania","volume":"8","author":"Frey","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.isci.2024.109284_bib63","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1523\/JNEUROSCI.18-08-02974.1998","article-title":"Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation","volume":"18","author":"Murray","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.isci.2024.109284_bib64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pnpbp.2014.08.013","article-title":"The role of neurotrophins in bipolar disorder","volume":"56","author":"Scola","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.isci.2024.109284_bib65","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbi.2021.11.020","article-title":"Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study","volume":"100","author":"Karthikeyan","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.isci.2024.109284_bib66","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jad.2018.10.370","article-title":"The role of neurotrophic factors in manic-anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder","volume":"245","author":"Valvassori","year":"2019","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.isci.2024.109284_bib67","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.euroneuro.2007.03.002","article-title":"Chronic amphetamine treatment reduces NGF and BDNF in the rat brain","volume":"17","author":"Angelucci","year":"2007","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.isci.2024.109284_bib68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jpsychires.2015.05.006","article-title":"Memory and brain-derived neurotrophic factor after subchronic or chronic amphetamine treatment in an animal model of mania","volume":"68","author":"Fries","year":"2015","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.isci.2024.109284_bib69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40345-020-00207-z","article-title":"Has Bipolar Disorder become a predominantly female gender related condition? Analysis of recently published large sample studies","volume":"9","author":"Dell'Osso","year":"2021","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.isci.2024.109284_bib70","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jad.2018.11.007","article-title":"Sex-specific effects of gain-of-function P2RX7 variation on bipolar disorder","volume":"245","author":"Winham","year":"2019","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.isci.2024.109284_bib71","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuropharm.2011.04.001","article-title":"Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia","volume":"61","author":"van den Buuse","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.isci.2024.109284_bib72","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00213-012-2860-4","article-title":"Sex differences in novelty- and psychostimulant-induced behaviors of C57BL\/6 mice","volume":"225","author":"Van Swearingen","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.isci.2024.109284_bib74","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1084\/jem.187.9.1463","article-title":"Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha\/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion","volume":"187","author":"Horai","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2024.109284_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1074\/jbc.M006781200","article-title":"Altered cytokine production in mice lacking P2X(7) receptors","volume":"276","author":"Solle","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.109284_bib76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/vcp.12886","article-title":"Arrive Guidelines 2.0","volume":"49","author":"Sprague","year":"2020","journal-title":"Vet. Clin. Pathol."},{"key":"10.1016\/j.isci.2024.109284_bib77","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2007.09.011","article-title":"Bimodal effect of amphetamine on motor behaviors in C57BL\/6 mice","volume":"427","author":"Yates","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.isci.2024.109284_bib78","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbr.2012.03.027","article-title":"Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse","volume":"231","author":"Enman","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.isci.2024.109284_bib79","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jpsychires.2019.09.003","article-title":"Effects of lithium and valproate on behavioral parameters and neurotrophic factor levels in an animal model of mania induced by paradoxical sleep deprivation","volume":"119","author":"Dal-Pont","year":"2019","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.isci.2024.109284_bib80","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbi.2022.01.015","article-title":"Maternal P2X7 receptor inhibition prevents autism-like phenotype in male mouse offspring through the NLRP3-IL-1beta pathway","volume":"101","author":"Szab\u00f3","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.isci.2024.109284_bib81","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1476-5381.2010.01068.x","article-title":"Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [18F]-IL1RA and PET imaging in rats","volume":"162","author":"Cawthorne","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.isci.2024.109284_bib82","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.jcbfm.9600537","article-title":"Interleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrations","volume":"28","author":"Clark","year":"2008","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.isci.2024.109284_bib83","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1038\/s41598-019-42410-8","article-title":"Mediatory roles of leukotriene B(4) receptors in LPS-induced endotoxic shock","volume":"9","author":"Kwon","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.109284_bib84","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31887\/DCNS.2017.19.2\/wcarlezon","article-title":"Behavioral methods to study anxiety in rodents","volume":"19","author":"Lezak","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.isci.2024.109284_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.beproc.2022.104670","article-title":"An overview of the currency and usefulness of behavioral tests used from past to present to assess anxiety, social behavior and depression in rats and mice","volume":"200","author":"Acikgoz","year":"2022","journal-title":"Behav. Processes"},{"key":"10.1016\/j.isci.2024.109284_bib86","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2015.07.027","article-title":"Chronic treatment with mood stabilizer lithium inhibits amphetamine-induced risk-taking manic-like behaviors","volume":"603","author":"Zhou","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.isci.2024.109284_bib87","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/jth.13684","article-title":"Contribution of platelet P2Y12 receptors to chronic Complete Freund's adjuvant-induced inflammatory pain","volume":"15","author":"Bek\u0151","year":"2017","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.isci.2024.109284_bib88","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.2002.00920.x","article-title":"Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus","volume":"81","author":"Sperl\u00e1gh","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.isci.2024.109284_bib89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.chroma.2006.03.018","article-title":"Chromatographic analysis of dopamine metabolism in a Parkinsonian model","volume":"1120","author":"Baranyi","year":"2006","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/j.isci.2024.109284_bib90","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J.\u00a0Pharmacol. Pharmacother."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224005054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224005054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:55:43Z","timestamp":1753869343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224005054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2589004224005054"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.109284","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2X7 receptor inhibition alleviates mania-like behavior independently of interleukin-1\u03b2","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.109284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109284"}}